Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Fulcrum Therapeutics, Inc. - Common Stock
(NQ:
FULC
)
11.64
+0.06 (+0.56%)
Streaming Delayed Price
Updated: 12:07 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fulcrum Therapeutics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
The Law Offices of Frank R. Cruz Announces Investigation of Fulcrum Therapeutics, Inc. (FULC) on Behalf of Investors
March 01, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
↗
February 28, 2023
Via
Benzinga
uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
February 28, 2023
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Fulcrum Therapeutics
↗
February 27, 2023
Via
Benzinga
Expert Ratings for Fulcrum Therapeutics
↗
January 19, 2023
Via
Benzinga
Why Fulcrum Therapeutics Shares Are Falling
↗
January 18, 2023
Fulcrum Therapeutics Inc (NASDAQ: FULC) shares are trading lower by 6.43% to $13.09 Wednesday morning after the company announced pricing of an upsized public offering of common stock.
Via
Benzinga
Dow Dips 350 Points; S&P 500 Down Over 1%
↗
February 24, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500...
Via
Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
February 24, 2023
Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.
Via
Benzinga
Stocks Extend Slump, Head For Weekly Losses
↗
February 24, 2023
Stocks are extending their premarket losses, with the Dow Jones Industrial Average down 409 points.
Via
Talk Markets
Looking Into Fulcrum Therapeutics's Return On Capital Employed
↗
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 24, 2023
Via
Benzinga
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
↗
February 24, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also...
Via
Benzinga
FDA Slams Break On Fulcrum Therapeutics' Sickle Cell Disease Study, Shares Plummet
↗
February 24, 2023
Via
Benzinga
Fulcrum Therapeutics (FULC) Stock Plummets 55% on Clinical Hold News
↗
February 24, 2023
FULC stock is falling fast today due to a regulatory issue, but Fulcrum Therapeutics remains committed to combating sickle cell disease.
Via
InvestorPlace
US Stocks Open Lower; Dow Drops 1%
↗
February 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Friday. Following the market opening Friday, the Dow traded down 1.05% to 32,807.33 while the NASDAQ fell 1.52% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 24, 2023
Via
Benzinga
Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
February 24, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 10, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
February 08, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
$30M Bet On Deciphera Pharmaceuticals? Check Out These 4 Stocks Insiders Are Buying
↗
January 25, 2023
Although US stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
The Week In Charts - Becoming A Successful Trader
↗
January 21, 2023
Dave discusses various topics, including intra-day trading and trading opening gap reversals, the current stock market conditions, and his two cents on your favorite stock picks.
Via
Talk Markets
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
January 17, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 17, 2023
Via
Benzinga
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
January 17, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
January 16, 2023
Via
Benzinga
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 13, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
$3.4 Million Bet On CrowdStrike Holdings? Check Out These 3 Stocks Insiders Are Buying
↗
January 09, 2023
Although US stocks closed sharply higher on Friday, there were a few notable insider trades.
Via
Benzinga
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
January 04, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Announces CEO Transition
January 04, 2023
Robert J. Gould, Ph.D., former president and founding chief executive officer of Fulcrum, is appointed as interim CEO as Bryan Stuart departs to pursue other opportunities
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
↗
December 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
